21.482 makale bulundu

Sinükleinopatik hastalığın önlenmesi ve tedavisi

Prevention and treatment of synucleinopathic disease

SCHENK DALE B, MASLIAH ELIEZER.

· 2003-10-31

Grup III metabotropik glutamat reseptörünün allosterik modülasyonu 4: Parkinson hastalığı tedavisine potansiyel bir yaklaşım.

Allosteric modulation of group III metabotropic glutamate receptor 4: a potential approach to Parkinson's disease treatment.

Marino MJ, Williams DL, O'Brien JA, Valenti O, McDonald TP, Clements MK, Wang R, DiLella AG, Hess JF, Kinney GG, Conn PJ.

Proc Natl Acad Sci U S A · 2003-10-30

DOI: 10.1073/pnas.1835724100PMID: 14593202

Depresyonun önlenmesi veya tedavisi için ilaç bileşimi, Parkinson hastalığı, idazolazoksan tuzu veya idazol hidrat, mikrokristalin selüloz, yağlayıcı, kolloidal silika ve laktoz içerir.

Pharmaceutical composition for prevention or treatment of e.g. depression, Parkinson's disease comprises idazoxan salt or idazoxan hydrate, microcrystalline cellulose, lubricant, colloidal silica and lactose

BOUGARET JOEL, AVAN JEAN LOUIS, SEGONDS ROLAND.

· 2003-10-28

KANSER VE KAŞEKSİYONUN TEDAVİ VE ÖNLEMLERİ VE KANSER VE KAŞEKSİYONUN ÖNLEM VE ÖNLENMESİ İÇİN ÖZEL AJENLERİN YENİ KULLANIMI

METHOD OF SCREENING AGENTS FOR THE TREATMENT AND PREVENTION OF CANCER AND CACHEXIA AND THE NEW USE OF SPECIFIC AGENTS FOR THE TREATMENT AND PREVENTION OF CANCER AND CACHEXIA

ARDIES C MURRAY.

· 2003-10-27

ADENOSINE A2A RECEPTOR ANTAGONİSTS PARKINSON SASLI ⁇ IN TEDAVİSİNDE NEUROTROPHİK AKTİVİTE KOMPOZLARI İLE BİRLEŞTİRİLMİŞtir.

ADENOSINE A2A RECEPTOR ANTAGONISTS COMBINED WITH NEUROTROPHIC ACTIVITY COMPOUNDS IN THE TREATMENT OF PARKINSON S DISEASE.

PETERS DAN.

· 2003-10-08

Alzheimer veya Parkinson hastalığının tedavisi için alfa 2B veya 2B / 2C adrenoseptör agonistlerinin kullanımı

Use of alpha 2B or 2B/2C adrenoceptor agonists for the treatment of Alzheimer's or Parkinson's disease

WHEELER LARRY A, GIL DANIEL W, DONELLO JOHN E.

· 2003-10-07

Demans ve Parkinson tedavisinde (2-imidazolin-2-ylamino) qinoxalines kullanma yöntemi

Method of using (2-imidazolin-2-ylamino) qinoxalines in the treatment of dementia and Parkinsons

TATTON WILLIAM G WHEELER LARRY.

· 2003-10-07

DEMENTİ VE PARKINSONLARIN TEDAVİSİNDE KULLANIM YÖNTEMİ (2-IMIDAZOLIN-2-YLAMINO) QINOXALINES

METHOD OF USING (2-IMIDAZOLIN-2-YLAMINO) QINOXALINES IN THE TREATMENT OF DEMENTIA AND PARKINSONS

TATTON WILLIAM G, WHEELER LARRY A, GIL DANIEL W, DONELLO JOHN E.

· 2003-10-07

NEURODEJENERASYON TEDAVİSİ İÇİN YÖNTEMLER

METHODS FOR THE TREATMENT OF NEURODEGENERATION

DONELLO JOHN E, GIL DANIEL W, WHEELER LARRY A.

· 2003-10-07

DEMENTIA VE PARKINSON'UN HASTALIKLARININ TEDAVİSİ

TREATMENT OF DEMENTIA AND PARKINSON'S DISEASE

GIL DANIEL W, DONELLO JOHN E, WHEELER LARRY A, TATTON WILLIAM G.

· 2003-10-07

ALZHEIMER'İN HASTALIKLARININ TEDAVİSİ İÇİN DUAL BİNA SİTESİ ACETYLCHOLINESTERASE INHIBITORS

DUAL BINDING SITE ACETYLCHOLINESTERASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE

MARTINEZ GIL ANA, GARCIA PALOMERO ESTHER, USAN EGEA PAOLA, DE AUSTRIA CELIA, DEL MONTE MILLAN MARIA, FUERTES HUERTA ANA, MORALES-ALCELAY SUSANA, RUBIO ARRIETA LAURA, MEDINA PADILLA MIGUEL, ALONSO GORDILLO DIANA, DORRONSORO DIAZ ISABEL.

· 2003-10-07

DEMENTİ VE PARKINSONLARIN TEDAVİSİNDE KULLANIM YÖNTEMİ (2-IMIDAZOLIN-2-YLAMINO) QINOXALINES

METHOD OF USING (2-IMIDAZOLIN-2-YLAMINO) QINOXALINES IN THE TREATMENT OF DEMENTIA AND PARKINSONS

TATTON WILLIAM G, WHEELER LARRY A, GIL DANIEL W, DONELLO JOHN E.

· 2003-10-07